Fierce Biotech News & Reports
WEB3 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
MedTech | Fierce Biotech
WEB3 days ago · The agency's researchers will conduct experiments to measure the amounts of metals that may leech out of tampons and enter the body under normal use. Conor Hale Sep 11, 2024 10:00am. Connect. The ...
Gilead backs out of option to buy immunotherapy-focused Tizona
WEBFeb 6, 2024 · Gilead will not buy immunotherapy biotech Tizona Therapeutics, backing out of an option that the company paid $300 million for in 2020. The pharma's opt-in oncology program with the biotech was ...
FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer
WEBAug 21, 2024 · FDA rejects Regeneron's blood cancer bispecific, delaying would-be challenger to J&J and Pfizer. The FDA has thrown a wrench in Regeneron’s plans to challenge Johnson & Johnson and Pfizer in a ...
The top biotech hubs in 2022 - Fierce Biotech
WEBBy Annalee Armstrong Jul 5, 2022 12:00am. startups real estate venture capital (VC) small biotechs. Top cities for biotechs include Boston, San Francisco, San Diego and a little corner of North ...
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
WEBBy Heather Landi Aug 21, 2024 11:00am. PreciseDx funding round venture capital (VC) Cancer. Cancer diagnostics startup PreciseDx picked up $20.7 million in series B funding as it ramps up ...
Genentech to close cancer immunology research department
WEBBy Angus Liu Aug 16, 2024 11:08am. Roche Genentech immuno-oncology layoffs. Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman ...
Roche working to enhance lab testing capacity for mpox - Fierce …
WEBBy Heather Landi Aug 21, 2024 12:30pm. Roche mpox diagnostic Laboratories. Roche says it's actively working with its partners to enhance mpox laboratory capacity worldwide to develop diagnostic ...
Gilead gives up on $4.9B antibody magrolimab - Fierce Biotech
WEBApr 26, 2024 · Gilead Sciences solid tumor R&D monoclonal antibody. A $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 ...
Firefly Bio assembles with $94M and an ADC dream team - Fierce …
WEBFeb 15, 2024 · It was time. Firefly Bio, assemble. Today, that company breaks stealth with $94 million co-led by Versant and MPM BioImpact, plus Decheng Capital and Eli Lilly. Firefly has a novel platform to ...
Skip to content